Briefing: STAT+: Eli Lilly and the ‘societal obligation’ of GLP-1s

Eli Lilly emphasizes the importance of GLP-1 medications.

Merck's acquisition of Terns Pharma is highlighted.

The newsletter covers various biotech developments.